Table 4.
Local progression | |||||
---|---|---|---|---|---|
Yes | No | Total | |||
Size-dose | TS < 1 cm | Count | 1 | 6 | 7 |
group | 22–24 Gy/1 fx | % within group | 11.1% | 66.7% | 100.0% |
TS < 1 cm | Count | 4 | 13 | 17 | |
18–20 Gy/1 fx | % within group | 23.5% | 76.5% | 100.0% | |
TS < 1 cm | Count | 3 | 2 | 5 | |
12–16 Gy/1 fx | % within group | 60.0% | 40.0% | 100.0% | |
TS 1.1–2 cm | Count | 0 | 3 | 3 | |
22–24 Gy/1 fx | % within group | 0.0% | 100.0% | 100.0% | |
TS 1.1–2 cm | Count | 3 | 12 | 15 | |
18–20 Gy/1 fx | % within group | 18.8% | 75.0% | 100.0% | |
TS 1.1–2 cm | Count | 9 | 8 | 17 | |
12–16 Gy/1 fx | % within group | 52.9% | 47.1% | 100.0% | |
Total | Count | 20 | 44 | 64 | |
% within group | 29.9% | 65.7% | 100.0% |
Lesions for which the response was not known were excluded.
TS, tumor size (diameter). Chi-square test not valid because of small numbers in some cells.